Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.

Yokouchi H, Nishihara H, Kenmotsu Y, Tsuji K, Kishikawa T, Kikuchi H, Miyauchi E, Nagano Y, Kanazawa K, Sugisaka J, Ohkuri T, Oizumi S

Open source

DOI: 10.2147/itt.s585001
Published: 2026
Container: ImmunoTargets and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/itt.s585001,
  title = {Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.},
  author = {Yokouchi H and Nishihara H and Kenmotsu Y and Tsuji K and Kishikawa T and Kikuchi H and Miyauchi E and Nagano Y and Kanazawa K and Sugisaka J and Ohkuri T and Oizumi S},
  year = {2026},
  journal = {ImmunoTargets and therapy},
  doi = {10.2147/itt.s585001},
  url = {https://doi.org/10.2147/itt.s585001}
}

RIS

TY  - JOUR
TI  - Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.
AU  - Yokouchi H
AU  - Nishihara H
AU  - Kenmotsu Y
AU  - Tsuji K
AU  - Kishikawa T
AU  - Kikuchi H
AU  - Miyauchi E
AU  - Nagano Y
AU  - Kanazawa K
AU  - Sugisaka J
AU  - Ohkuri T
AU  - Oizumi S
PY  - 2026
JO  - ImmunoTargets and therapy
DO  - 10.2147/itt.s585001
UR  - https://doi.org/10.2147/itt.s585001
ER  -

APA

H, Y., H, N., Y, K., K, T., T, K., H, K., E, M., Y, N., K, K., J, S., T, O., & S, O. (2026). Prognostic Significance of Tumor-Cell VISTA Expression on Survival Outcomes in Nivolumab-Treated Pleural Mesothelioma: The HOT1901 Retrospective Multi-Institutional Study.. ImmunoTargets and therapy. https://doi.org/10.2147/itt.s585001

Source records

pubmed · retrieved 2026-09-25T00:30:56.638Z